NCT07229027 Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
| NCT ID | NCT07229027 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medialis Ltd. |
| Condition | Overweight (BMI > 25) |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-11-01 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
Eligibility Criteria
Inclusion Criteria: * Patient group 1. Patient is aged ≥18 years at the time of survey completion. 2. Patient has a BMI over 25 (self-reported) 3. Patient is willing to participate in all study activities. 4. Patient is able to read, write, and converse in English. * Healthcare professional participant must meet the following criteria for inclusion in the study: 1. HCP is aged ≥18 years at the time of survey completion. 2. HCP is suitably qualified and involved in the healthcare management of patients with a BMI over 25 3. HCP is willing to participate in all study activities. 4. HCP is able to read, write, and converse in English. Exclusion Criteria: A participant who meets any of the following criteria will be excluded from the study: 1. Participants do not have the cognitive capacity to provide informed consent. 2. Participants with severe co-morbidity that might affect study participation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07229027 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Overweight (BMI > 25). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07229027 currently recruiting?
Yes, NCT07229027 is actively recruiting participants. Contact the research team at omolade@medialis.co.uk for enrollment information.
Where is the NCT07229027 trial being conducted?
This trial is being conducted at Milton Keynes, United Kingdom.
Who is sponsoring the NCT07229027 clinical trial?
NCT07229027 is sponsored by Medialis Ltd.. The trial plans to enroll 500 participants.